January 28, 2012

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin

.   .   

Patients who are desensitized prior to renal transplant require more intensive immunosuppression compared to average-risk patients. In this single-centre, non-randomized study, the use of rituximab was not associated with an increased risk of bacterial, viral or fungal infections.

Related Articles:

Renal Transplantation

Comments are closed.